Lumivascular, Inc.
52 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
6
Ending by 2030
May 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 16, 2026The maintenance fee for Optical Coherence Tomography with Graded Index Fiber for Biological Imaging (US 11,647,905) comes due Nov 16, 2026. Unpaid by May 17, 2027, it lapses early.
- 1 fee due Jan 9, 2027The maintenance fee for Optical Coherence Tomography for Biological Imaging (US 10,342,491) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
- 1 fee due Feb 15, 2027The maintenance fee for Optical Pressure Sensor Assembly (US 11,723,538) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
- 1 fee due Mar 8, 2027The maintenance fee for Catheter-Based Off-Axis Optical Coherence Tomography Imaging System (US 9,125,562) comes due Mar 8, 2027. Unpaid by Sep 8, 2027, it lapses early.
- 1 fee due Jun 12, 2027The maintenance fee for Optical Coherence Tomography for Biological Imaging (US 11,839,493) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
- 1 fee due Aug 25, 2027The maintenance fee for Micro-Molded Anamorphic Reflector Lens for Image Guided Therapeutic/Diagnostic Catheters (US 10,568,520) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
- 1 fee due Oct 2, 2027The maintenance fee for Identification of Elastic Lamina to Guide Interventional Therapy (US 11,944,342) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
- 1 fee due Nov 7, 2027The maintenance fee for Micro-Molded Anamorphic Reflector Lens for Image Guided Therapeutic/Diagnostic Catheters (US 11,974,830) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,342,491 | Optical Coherence Tomography for Biological Imaging In force · High confidence | In force | High confidence | |
| US 11,839,493 | Optical Coherence Tomography for Biological Imaging In force · Medium confidence | In force | Medium confidence | |
| US 12,178,613 | Optical Coherence Tomography for Biological Imaging In force · High confidence | In force | High confidence | |
| US 9,125,562 | Catheter-Based Off-Axis Optical Coherence Tomography Imaging System In force · High confidence | In force | High confidence | |
| US 10,729,326 | Catheter-Based Off-Axis Optical Coherence Tomography Imaging System In force · High confidence | In force | High confidence | |
| US 12,053,260 | Catheter-Based Off-Axis Optical Coherence Tomography Imaging System In force · High confidence | In force | High confidence | |
| US 8,548,571 | Devices and Methods for Predicting and Preventing Restenosis In force · High confidence | In force | High confidence | |
| US 11,135,019 | Occlusion-Crossing Devices, Atherectomy Devices, and Imaging In force · High confidence | In force | High confidence | |
| US 12,257,003 | Occlusion-Crossing Devices, Atherectomy Devices, and Imaging In force · High confidence | In force | High confidence | |
| US 9,345,406 | Occlusion-Crossing Devices, Atherectomy Devices, and Imaging In force · High confidence | In force | High confidence |
Also on record, not counted in the 24: 52 patents in force now held by others · 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.